Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in China.
about
Incorporating bazedoxifene into the treatment paradigm for postmenopausal osteoporosis in Japan.Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosisAssociation of blood neutrophil lymphocyte ratio in the patients with postmenopausal osteoporosis
P2860
Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in China.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparison of parathyroid horm ...... ter controlled trial in China.
@en
Comparison of parathyroid horm ...... ter controlled trial in China.
@nl
type
label
Comparison of parathyroid horm ...... ter controlled trial in China.
@en
Comparison of parathyroid horm ...... ter controlled trial in China.
@nl
prefLabel
Comparison of parathyroid horm ...... ter controlled trial in China.
@en
Comparison of parathyroid horm ...... ter controlled trial in China.
@nl
P2093
P1476
Comparison of parathyroid horm ...... nter controlled trial in China
@en
P2093
Cheng-jiang Li
Gang-yi Yang
Hong Zhang
Jiu-cui Tong
Peng-qiu Li
Qing-yun Xue
P304
P407
P577
2013-02-01T00:00:00Z